Open Access
Open access

Ecotoxicology and Environmental Safety

Elsevier
Elsevier
ISSN: 01476513, 10902414

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q1
Impact factor
6.2
SJR
1.418
CiteScore
12.1
Categories
Health, Toxicology and Mutagenesis
Medicine (miscellaneous)
Pollution
Public Health, Environmental and Occupational Health
Areas
Environmental Science
Medicine
Years of issue
1977-2025
journal names
Ecotoxicology and Environmental Safety
ECOTOX ENVIRON SAFE
Publications
16 978
Citations
491 369
h-index
190
Top-3 citing journals
Chemosphere
Chemosphere (20957 citations)
Top-3 organizations
Zhejiang University
Zhejiang University (210 publications)
Nanjing Agricultural University
Nanjing Agricultural University (160 publications)
Top-3 countries
China (6961 publications)
USA (1442 publications)
India (966 publications)

Most cited in 5 years

Found 
from chars
Publications found: 2872
Relationship between lipoprotein B and the severity of coronary microvascular dysfunction
Yang L., Zhang J., Han J., Jiang X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
Han J.H., Sharapatov Y., Do M., Kim S.Y., Han B., Choi E., Jeong C.W.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
High-salt diets provoke phosphorus absorption from the small intestine in mice
Yang M., You H., Ni L., Mao J., Chen J.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Efficacy and safety of intensive blood pressure control in patients over 60 years: A systematic review and meta-analysis
Yang H., Xing H., Zou X., Jin M., Li Y., Xiao K., Cai L., Liu Y., Yang X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism
Zhang K., Deng X., Li Z., Yi C., Kong J., Wang Y.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Tanaka M., Akiyama Y., Mori K., Hosaka I., Endo K., Ogawa T., Sato T., Suzuki T., Yano T., Ohnishi H., Hanawa N., Furuhashi M.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Restoration of vascular dysfunction resulting from maternal high-fat diet via modulation of the NLRP3/IL-1β axis
Xiao Y., Bi X., Zhang R., Li Y., Sun W., Hao Y.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 1
Open Access
Open access
PDF
Correction
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Uric acid mediates kidney tubular inflammation through the LDHA/ROS/NLRP3 pathway
Ouyang J., Wang H., Gan Y., Huang J.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
The association of schooling, sibling life situation, and dietary habits with the estimated 24-h urinary salt excretion and sodium-to-potassium ratio in 3-year-old children
Odani K., Yoshii K., Maruyama N., Takahata S., Kawazoe S., Miyawaki T., Higashi A.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring
Yang L., Zhu X., Zhu J., Hu Z., Wang C., Luo H., Bai X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway
Mao J., Zhang X., Wang C., Peng S.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Analysis of the current status and associated risk factors of cognitive function in Tibetan hypertensive patients at various altitudes
Yin L., Zhang X., Zhang H., Li R., Zeng J., Dong K., Wang Y., Li X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 1
Open Access
Open access
PDF
Causal relationship between gut microbiota, plasma metabolites, inflammatory cytokines and abdominal aortic aneurysm: a Mendelian randomization study
Li C., Liu Z., Yang S., Li W., Liang B., Chen H., Ye Y., Wang F., Liu X., Jiang Y., Wu H., Peng Y., Meng Z.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 3
Open Access
Open access
PDF
Expression of TGF-β/Smad pathway-related indices in patients with isolated iliac artery aneurysms complicated with iliac arteriovenous fistula and their relationship with prognosis
Zhu Z., Yao Y., Shen G., Wang H.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF

Top-100

Citing journals

5000
10000
15000
20000
25000
30000
Show all (70 more)
5000
10000
15000
20000
25000
30000

Citing publishers

50000
100000
150000
200000
250000
Show all (70 more)
50000
100000
150000
200000
250000

Publishing organizations

50
100
150
200
250
300
Show all (70 more)
50
100
150
200
250
300

Publishing organizations in 5 years

20
40
60
80
100
120
140
160
Show all (70 more)
20
40
60
80
100
120
140
160

Publishing countries

1000
2000
3000
4000
5000
6000
7000
China, 6961, 41%
USA, 1442, 8.49%
India, 966, 5.69%
Brazil, 640, 3.77%
Germany, 558, 3.29%
France, 519, 3.06%
Italy, 499, 2.94%
Canada, 481, 2.83%
Spain, 438, 2.58%
United Kingdom, 425, 2.5%
Republic of Korea, 319, 1.88%
Australia, 309, 1.82%
Portugal, 304, 1.79%
Poland, 297, 1.75%
Japan, 292, 1.72%
Netherlands, 281, 1.66%
Iran, 272, 1.6%
Pakistan, 268, 1.58%
Egypt, 204, 1.2%
Argentina, 198, 1.17%
Sweden, 166, 0.98%
Saudi Arabia, 150, 0.88%
Turkey, 145, 0.85%
Denmark, 142, 0.84%
Belgium, 133, 0.78%
Czech Republic, 120, 0.71%
Finland, 115, 0.68%
South Africa, 93, 0.55%
Mexico, 92, 0.54%
Switzerland, 90, 0.53%
Norway, 88, 0.52%
Tunisia, 83, 0.49%
Hungary, 73, 0.43%
Russia, 62, 0.37%
Greece, 61, 0.36%
Nigeria, 60, 0.35%
Malaysia, 58, 0.34%
Chile, 55, 0.32%
Croatia, 50, 0.29%
Austria, 42, 0.25%
Slovakia, 42, 0.25%
Thailand, 41, 0.24%
Serbia, 38, 0.22%
Bangladesh, 37, 0.22%
New Zealand, 37, 0.22%
Iraq, 28, 0.16%
Ireland, 28, 0.16%
Colombia, 28, 0.16%
Vietnam, 27, 0.16%
Slovenia, 23, 0.14%
Bulgaria, 19, 0.11%
Morocco, 19, 0.11%
Singapore, 18, 0.11%
Ukraine, 17, 0.1%
Kuwait, 17, 0.1%
Romania, 17, 0.1%
UAE, 16, 0.09%
Algeria, 15, 0.09%
Ghana, 15, 0.09%
Israel, 15, 0.09%
Oman, 15, 0.09%
Indonesia, 14, 0.08%
Georgia, 10, 0.06%
Sri Lanka, 10, 0.06%
Estonia, 8, 0.05%
Ecuador, 8, 0.05%
Qatar, 7, 0.04%
Democratic Republic of the Congo, 7, 0.04%
Lithuania, 7, 0.04%
Ethiopia, 7, 0.04%
Jordan, 6, 0.04%
Costa Rica, 6, 0.04%
Palestine, 6, 0.04%
Bolivia, 5, 0.03%
Uruguay, 5, 0.03%
Philippines, 5, 0.03%
Yugoslavia, 5, 0.03%
Zimbabwe, 4, 0.02%
Cyprus, 4, 0.02%
Mongolia, 4, 0.02%
Nepal, 4, 0.02%
Peru, 4, 0.02%
Bosnia and Herzegovina, 3, 0.02%
Zambia, 3, 0.02%
Kenya, 3, 0.02%
Cuba, 3, 0.02%
Latvia, 3, 0.02%
Lebanon, 3, 0.02%
Libya, 3, 0.02%
Monaco, 3, 0.02%
North Macedonia, 3, 0.02%
Senegal, 3, 0.02%
Jamaica, 3, 0.02%
Kazakhstan, 2, 0.01%
Belarus, 2, 0.01%
Azerbaijan, 2, 0.01%
Armenia, 2, 0.01%
Iceland, 2, 0.01%
Yemen, 2, 0.01%
Cambodia, 2, 0.01%
Show all (70 more)
1000
2000
3000
4000
5000
6000
7000

Publishing countries in 5 years

500
1000
1500
2000
2500
3000
3500
4000
4500
China, 4489, 58.1%
USA, 375, 4.85%
India, 155, 2.01%
Republic of Korea, 152, 1.97%
Pakistan, 137, 1.77%
Brazil, 126, 1.63%
United Kingdom, 122, 1.58%
France, 98, 1.27%
Australia, 96, 1.24%
Iran, 96, 1.24%
Spain, 95, 1.23%
Germany, 94, 1.22%
Saudi Arabia, 89, 1.15%
Canada, 85, 1.1%
Egypt, 81, 1.05%
Japan, 78, 1.01%
Italy, 69, 0.89%
Poland, 62, 0.8%
Sweden, 50, 0.65%
Netherlands, 45, 0.58%
Czech Republic, 39, 0.5%
Portugal, 34, 0.44%
Argentina, 32, 0.41%
Turkey, 30, 0.39%
Belgium, 25, 0.32%
Norway, 25, 0.32%
Russia, 24, 0.31%
Switzerland, 24, 0.31%
Denmark, 23, 0.3%
Malaysia, 23, 0.3%
Finland, 20, 0.26%
Bangladesh, 19, 0.25%
Nigeria, 19, 0.25%
Hungary, 16, 0.21%
Thailand, 15, 0.19%
Austria, 14, 0.18%
Mexico, 14, 0.18%
Tunisia, 13, 0.17%
South Africa, 13, 0.17%
Vietnam, 12, 0.16%
Iraq, 11, 0.14%
Slovakia, 11, 0.14%
Singapore, 10, 0.13%
Chile, 10, 0.13%
UAE, 9, 0.12%
Israel, 8, 0.1%
Colombia, 8, 0.1%
Serbia, 8, 0.1%
Greece, 7, 0.09%
Ireland, 7, 0.09%
New Zealand, 7, 0.09%
Indonesia, 6, 0.08%
Oman, 6, 0.08%
Romania, 6, 0.08%
Jordan, 5, 0.06%
Qatar, 5, 0.06%
Morocco, 5, 0.06%
Ukraine, 4, 0.05%
Bulgaria, 3, 0.04%
Ghana, 3, 0.04%
Democratic Republic of the Congo, 3, 0.04%
Costa Rica, 3, 0.04%
Kuwait, 3, 0.04%
Mongolia, 3, 0.04%
Peru, 3, 0.04%
Slovenia, 3, 0.04%
Sri Lanka, 3, 0.04%
Ecuador, 3, 0.04%
Kazakhstan, 2, 0.03%
Azerbaijan, 2, 0.03%
Algeria, 2, 0.03%
Bolivia, 2, 0.03%
Bosnia and Herzegovina, 2, 0.03%
Zambia, 2, 0.03%
Cameroon, 2, 0.03%
Cyprus, 2, 0.03%
Lithuania, 2, 0.03%
Luxembourg, 2, 0.03%
Palestine, 2, 0.03%
Rwanda, 2, 0.03%
Syria, 2, 0.03%
Ethiopia, 2, 0.03%
Belarus, 1, 0.01%
Estonia, 1, 0.01%
Venezuela, 1, 0.01%
Zimbabwe, 1, 0.01%
Iceland, 1, 0.01%
Latvia, 1, 0.01%
Libya, 1, 0.01%
Mauritius, 1, 0.01%
Nepal, 1, 0.01%
Panama, 1, 0.01%
Senegal, 1, 0.01%
Sudan, 1, 0.01%
Uganda, 1, 0.01%
Philippines, 1, 0.01%
Croatia, 1, 0.01%
Show all (67 more)
500
1000
1500
2000
2500
3000
3500
4000
4500